Physician profile
John Krause
NPI 1902809577
$6,894.76
in general payments reported to CMS, 2019-2025
16 companies · $55.67 in 2025
The $55.67 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $854 · 2021: $141 · 2022: $1,864 · 2023: $280 · 2024: $3,459 · 2025: $55.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $2,945 · Food and Beverage: $849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $2,945.00 |
| Food and Beverage | $849.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| International Rehabilitative Sciences, INC | $2,945.00 | 2024 | Rs 4i Plus Sequential Stimulator |
| Elite Orthopedics, LLC | $1,588.75 | 2019-2024 | |
| Zimmer Biomet Holdings, INC. | $683.34 | 2020 | |
| Stryker Corporation | $362.64 | 2019-2023 | Infinity |
| Arthrex, INC. | $358.00 | 2022 | |
| Paragon 28, INC. | $160.56 | 2023-2024 | Silverback, Baby Gorilla |
| Depuy Synthes Sales INC. | $158.88 | 2020-2024 | Na |
| Axogen | $138.12 | 2019-2020 | |
| Medline Industries Lp | $130.37 | 2022 | |
| Linvatec Corporation | $112.84 | 2024 | Biobrace 23mm |
| Smith+Nephew, INC. | $104.56 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $71.46 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $31.01 | 2024 | Exparel |
| Zimvie INC. | $19.39 | 2022 | |
| Highridge Medical LLC | $17.42 | 2024 | Biomet Ebi Bone Healing System |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trevena, INC. | $12.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Krause listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.